Brief: Transcenta Holding Says TST003 Received Ind Clearance From U.S. Food And Drug Administration
14/09/2022 07:38
Sept 14 (Reuters) - Transcenta Holding Limited 6628.HK :
* TST003 HAS RECEIVED IND CLEARANCE FROM U.S. FOOD AND DRUG
ADMINISTRATION
Source text for Eikon: ID:
Further company coverage: 6628.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transcenta Holding
See all newsBrief: Transcenta Says Global Phase III Trial Of Osemitamab Approved By FDA, China, Korea Regulators
Brief: Transcenta Holding Says Unit To Sell CDMO Assets For RMB190.0 Million
Brief: Transcenta Holding To Revert Assets To Lilly For $4 Million Cash
Brief: Transcenta Therapeutics Appoints Dr. Christopher Hwang As Head Of Global Partnerships For Hicb Platform
Brief: Transcenta Announces Collaboration And Non-Exclusive Licensing Agreement With Eirgenix Inc.